mannitol has been researched along with Airflow Obstruction, Chronic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacle, A; Becq, F; Cantereau, A; Ferreira, T; Ferru-Clément, R; Hélye, R; Jayle, C; Kadri, L; Payet, LA; Vandebrouck, C | 1 |
| Hutcheon, GA; Mohamed, A; Pekoz, AY; Ross, K; Saleem, IY | 1 |
| Andersen, LW; Buggeskov, KB; Jakobsen, JC; Jonassen, T; Secher, NH; Steinbrüchel, DA; Wetterslev, J | 1 |
| Austin, G; Bhowmik, A; Chahal, K; Chakravorty, I | 1 |
| Adi, H; Agus, H; Chan, HK; Traini, D; Young, PM | 1 |
| de Nijs, SB; Dijkers, E; Fens, N; Krouwels, FH; Lutter, R; Smids-Dierdorp, BS; Sterk, PJ; van Steenwijk, RP | 1 |
| Chhajed, PN; Jochmann, A; Leuppi, JD; Maier, S; Miedinger, D; Schafroth Török, S; Scherr, A; Taegtmeyer, AB; Tamm, M | 1 |
| Blanco-Vidal, MJ; Catalan-Urribarrena, G; del Aguila, C; Lopez, JI; Magnet, A; Montejo, M; Pomposo-Gaztelu, I | 1 |
| Andersen, LW; Buggeskov, KB; Jonassen, T; Secher, NH; Steinbrüchel, DA; Wetterslev, J | 1 |
| Anderson, SD; Andersson, M; Bingisser, R; Brutsche, MH; Chan, HK; Greiff, L; Knoblauch, A; Leuppi, JD; Perruchoud, AP; Stolz, D; Surber, C; Tamm, M; Tandjung, R | 1 |
| Bracciale, P; Salerno, FG; Valerio, G | 1 |
1 review(s) available for mannitol and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Improving mucociliary clearance in chronic obstructive pulmonary disease.
Topics: Diuretics, Osmotic; Exercise Therapy; Expectorants; High-Frequency Ventilation; Humans; Mannitol; Mucociliary Clearance; Physical Therapy Modalities; Positive-Pressure Respiration; Pulmonary Disease, Chronic Obstructive; Saline Solution, Hypertonic | 2009 |
4 trial(s) available for mannitol and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Detailed statistical analysis plan for the pulmonary protection trial.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Clinical Protocols; Data Interpretation, Statistical; Denmark; Glucose; Heart Diseases; Humans; Intraoperative Care; Length of Stay; Lung; Mannitol; Oxygen; Perfusion; Postoperative Complications; Potassium Chloride; Procaine; Pulmonary Disease, Chronic Obstructive; Research Design; Time Factors; Treatment Outcome | 2014 |
Airway inflammation and mannitol challenge test in COPD.
Topics: Administration, Inhalation; Aged; Anti-Inflammatory Agents; Bronchial Hyperreactivity; Bronchoconstriction; Cross-Sectional Studies; Female; Forced Expiratory Volume; Humans; Inflammation Mediators; Interleukin-8; Male; Mannitol; Middle Aged; Netherlands; Peroxidase; Pneumonia; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Pulmonary Eosinophilia; ROC Curve; Severity of Illness Index; Sputum; Treatment Outcome | 2011 |
Response to add-on inhaled corticosteroids in COPD based on airway hyperresponsiveness to mannitol.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Bronchial Hyperreactivity; Budesonide; Diuretics, Osmotic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Mannitol; Middle Aged; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Treatment Outcome | 2012 |
Pulmonary perfusion with oxygenated blood or custodiol HTK solution during cardiac surgery for postoperative pulmonary function in COPD patients: a trial protocol for the randomized, clinical, parallel group, assessor and data analyst blinded Pulmonary Pr
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Clinical Protocols; Glucose; Humans; Lung; Mannitol; Outcome Assessment, Health Care; Perfusion; Potassium Chloride; Procaine; Pulmonary Circulation; Pulmonary Disease, Chronic Obstructive; Sample Size; Systemic Inflammatory Response Syndrome | 2013 |
6 other study(ies) available for mannitol and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Modulation of cellular membrane properties as a potential therapeutic strategy to counter lipointoxication in obstructive pulmonary diseases.
Topics: Adult; Aged; Bronchi; Cell Line; Cell Membrane; Computer Simulation; Cystic Fibrosis; Epithelial Cells; Fatty Acids; Female; Humans; Male; Mannitol; Middle Aged; Molecular Dynamics Simulation; Oleic Acids; Phospholipids; Primary Cell Culture; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa | 2018 |
Pulmonary delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for treatment of COPD.
Topics: A549 Cells; Administration, Inhalation; Aerosols; Drug Carriers; Excipients; Humans; Interleukin-1 Receptor-Associated Kinases; Leucine; Mannitol; MicroRNAs; Nanocomposites; Polyesters; Powders; Pulmonary Disease, Chronic Obstructive | 2019 |
Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Anti-Infective Agents; Chemistry, Pharmaceutical; Ciprofloxacin; Cystic Fibrosis; Drug Combinations; Humans; Mannitol; Microbial Sensitivity Tests; Nebulizers and Vaporizers; Powders; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive; Staphylococcus aureus; Streptococcus pyogenes | 2010 |
[Left-sided hemiparesis in a diabetic patient: chronic granulomatous encephalitis due to Acanthamoeba].
Topics: Acanthamoeba; Aged; Alcoholism; Amebiasis; Anti-Infective Agents; Atrial Fibrillation; Biopsy; Brain Abscess; Chronic Disease; Dexamethasone; Diabetes Complications; Enterobacter cloacae; Enterobacteriaceae Infections; Fatal Outcome; Granuloma; Humans; Male; Mannitol; Meningoencephalitis; Paresis; Phenytoin; Pulmonary Disease, Chronic Obstructive; Surgical Wound Infection | 2013 |
Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Budesonide; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Histamine; Humans; Male; Mannitol; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Spirometry; Treatment Outcome; Vital Capacity | 2005 |
The i.v. infusion of mannitol decreases airway responsiveness to methacholine in asthma.
Topics: Airway Resistance; Asthma; Bronchoconstrictor Agents; Diuretics; Humans; Infusions, Intravenous; Male; Mannitol; Methacholine Chloride; Middle Aged; Osmotic Pressure; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Respiratory Mechanics | 2007 |